Shefferman Jesse sold $882K of TARA
Shefferman Jesse (CEO and President) sold 215,687 shares of Protara Therapeutics, Inc. (TARA) at $4.09 ($0.88M total) on 2026-06-29.
How this was made
The 30-second read
Why it matters
This is a new, concrete datapoint on CEO share disposal (215,687 shares at $4.09) but lacks any accompanying company-specific fundamental update.
Market read
Insider selling can modestly influence sentiment, but without additional catalysts it is unlikely to drive a sustained repricing.
What to watch
Traders may want to compare this sale to prior insider activity (frequency/size) and whether other insiders filed concurrent transactions, which are not provided here.
Background
The article is an SEC Form 4 insider transaction disclosure for Protara Therapeutics, Inc. (TARA).
Ticker impact
Protara Therapeutics CEO Jesse Shefferman sold 215,687 shares in an open-market transaction for about $882K, per Form 4 filed July 1.
Low near-term impact; any effect is likely sentiment-driven and limited unless follow-on selling accelerates.
The filing is a primary-source Form 4 with transaction size and price, but it does not include new guidance, trial results, or material corporate events.
Market effects
Minimal; insider-sale disclosures typically do not change sector fundamentals without accompanying company-specific news.
None indicated.
None indicated.
Counterpoint
The sale could be driven by diversification or pre-planned liquidity needs rather than negative fundamentals, especially since it references no 10b5-1 plan.
Key entities
- issuerProtara Therapeutics, Inc.
Subject of the Form 4 insider transaction; CEO and President Jesse Shefferman sold shares.
- insiderJesse Shefferman
CEO and President who executed the open-market sale disclosed in the Form 4.